Abstract
Biomedical research has traditionally been slow and incremental, but the COVID-19 pandemic prompted a rapid break from this standard. The cornerstones of health research funding – gradual change and risk aversion – went out the window as the global medical community turned its attention to finding treatments and vaccines for COVID as fast as possible.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
